Bitopertin: the good news and bad news

JAMA Psychiatry. 2014 Jun;71(6):621-2. doi: 10.1001/jamapsychiatry.2014.257.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antipsychotic Agents / therapeutic use*
  • Female
  • Glycine Plasma Membrane Transport Proteins / antagonists & inhibitors*
  • Humans
  • Male
  • Piperazines / therapeutic use*
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology*
  • Sulfones / therapeutic use*

Substances

  • (4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl)(5-methanesulfonyl-2-(2,2,2-trifluoro-1-methylethoxy)phenyl)methanone
  • Antipsychotic Agents
  • Glycine Plasma Membrane Transport Proteins
  • Piperazines
  • SLC6A9 protein, human
  • Sulfones